Colposcopy is widely used to detect cervical cancers, but experienced physicians who are needed for an accurate diagnosis are lacking in developing countries. Artificial intelligence (AI) has been recently used in computer-aided diagnosis showing remarkable promise. In this study, we developed and validated deep learning models to automatically classify cervical neoplasms on colposcopic photographs. Pre-trained convolutional neural networks were fine-tuned for two grading systems: the cervical intraepithelial neoplasia (CIN) system and the lower anogenital squamous terminology (LAST) system. The multi-class classification accuracies of the networks for the CIN system in the test dataset were 48.6 ± 1.3% by Inception-Resnet-v2 and 51.7 ± 5.2% by Resnet-152. The accuracies for the LAST system were 71.8 ± 1.8% and 74.7 ± 1.8%, respectively. The area under the curve (AUC) for discriminating high-risk lesions from low-risk lesions by Resnet-152 was 0.781 ± 0.020 for the CIN system and 0.708 ± 0.024 for the LAST system. The lesions requiring biopsy were also detected efficiently (AUC, 0.947 ± 0.030 by Resnet-152), and presented meaningfully on attention maps. These results may indicate the potential of the application of AI for automated reading of colposcopic photographs. Cervical cancer is the fourth most common cancer in women worldwide, and the second most common cancer among females in developing countries 1. Screening is the principal prevention method aimed at reducing mortality rates. Screening includes certain steps, including population-based Papanicolaou (Pap) testing, colposcopydirected biopsy of suspicious lesions, and the treatment of confirmed pre-cancer lesions 2,3. In women with low-grade intraepithelial lesions (LSIL) or high-grade intraepithelial lesions (HSIL), the risk of pre-cancer is medium to high, and immediate referral for colposcopy is necessary. However, referring all women with atypical squamous cells of undetermined significance (ASC-US) is considered inefficient, as the risk of such cases being pre-cancerous is lower 4. Screening programs have been successful in the developed countries, leading to an approximately 80% decrease in the cervical cancer incidence over the past 4 decades. In contrast, the increase in cervical cancer incidence reported in developing countries 5 has been attributed to the unsuccessful implementation of screening programs. This, has been attributed to logistics in health systems, infrastructural inadequacies, and the lack of expert physicians capable of introducing screening programs and follow-up 6 .